In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - COG-ACCL2031
Protocol Summary
- Protocol No
- COG-ACCL2031
- Principal Investigator
- Sarah Rumler
- Phase
- III
- Title
- A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine (IND# 149832) for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors
- Associated Disease(s)
-
Brain and Spinal Cord Tumors
- Description (Summary)
- The overall goals of this study are: To see if taking memantine compared to taking a placebo for 6 months makes a difference in cognitive function for children and adolescents receiving radiation therapy for a brain tumor. It will also study results from cognitive function tests, brain images, and lab tests in children and adolescents taking memantine compared to children and adolescents taking placebo.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
